- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01895647
Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure
Difference of Muscle Power and Myokine Profile After Upper Limb or Lower Limb Electric Muscle Stimulation in Patients With Severe Sepsis and Acute Respiratory Failure
Rationale : Electric muscle stimulation reduced critical-illness related weakness in patients with severe sepsis and septic shock. But optimal protocol of the stimulation in unknown.
Hypothesis: Focal muscle contraction may improved the muscle power and have systemic anti-inflammatory via cytokine secretion . The difference of electricity used in upper limb or lower limb stimulation may lead to different effect.
Study design: Stratified randomized parallel control study, comparing Biceps, Quadriceps electric muscle stimulation vs. non-stimulation group.
Participant: adult patients with severe sepsis and acute respiratory failure requiring mechanical ventilation.
Intervention: daily stimulation of bilateral Biceps or Quadriceps by programmed electric devices 32 minutes, 5 days/week
Outcome:
- Primary outcome: Ventilator-dependent days
- Secondary outcome: change of hand drip muscle power/interleukin-1b/interleukin-6/interleukin-8/TNF-alpha
Study Overview
Status
Intervention / Treatment
Detailed Description
Background : Severe sepsis and septic shock remain top cause of admission to intensive care unit. Muscle weakness was found in 70-100% patients with severe sepsis and septic shock because of critical-illness induced polyneuropathy and myopathy. Previous study revealed electric muscle stimulation (EMS) could reduce such muscle weakness and mechanical ventilator-dependent days.
Hypothesis: different electricity may be needed for minimal contraction of upper or lower limb because of their muscle size. Induced muscle contraction may lead to myokine secretion and beneficial metabolic and anti-inflammatory effect. Stimulation on Quadriceps may be better than on Biceps.
Participant: adult(older than 20 years-old) patients with severe sepsis.septic shock and acute respiratory failure post mechanical ventilation.
Design: Stratified ( gender and age >50 years-old) Randomized parallel 3 arms study.
Intervention: Daily stimulation of Biceps of Quadriceps after third days in intensive care unit. Programmed electric stimulation device ( HELEX 573 model, strength aggressive. mode, 45-55Hz 32 minutes per day, voltage 30-70mA)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 10449
- Mackay Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- severe sepsis or septic shock patients with acute respiratory failure more than 3 days
- adult patients( age>20 years-old)
Exclusion Criteria:
- skin wound/infection near the site of muscle stimulation
- acute myocardial infarction within 7 days
- pregnant women
- uncontrolled epilepsy
- no spontaneous breath because of central or cervical spinal neuropathy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Biceps stimulation
EMS
|
Electric muscle stimulation with programmed warm-up, stimulation and cool-down in 32 minutes
Other Names:
|
EXPERIMENTAL: Quadriceps stimulation
EMS
|
Electric muscle stimulation with programmed warm-up, stimulation and cool-down in 32 minutes
Other Names:
|
NO_INTERVENTION: Control
Control group without electric muscle stimulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ventilator-dependant Days
Time Frame: 21 days
|
Patient days on mechanical ventilator ( Our National Health Insurance provide 21 days for acute intensive care at most)
|
21 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle Strength Improvement
Time Frame: 21 days
|
muscle power measurement by hand grip digital dynamometer every 2 days
|
21 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inflammatory Cytokine Change
Time Frame: First 1 week.
|
Serum interleukin(IL)-1B, IL-6, IL-8, IL-10, IL-15 and tumor necrosis factor(TNF)-alpha will be measured before/after first section of EMS, and after fifth EMS section.
|
First 1 week.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kuang H Cheng, Msc, Mackay Memorial Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Infections
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Systemic Inflammatory Response Syndrome
- Neurologic Manifestations
- Neuromuscular Manifestations
- Sepsis
- Toxemia
- Inflammation
- Respiratory Insufficiency
- Respiratory Distress Syndrome
- Muscle Hypotonia
Other Study ID Numbers
- 13MMHIS060
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Singapore National Eye CentreCompletedIntraocular Inflammation in ChildrenSingapore
Clinical Trials on EMS
-
Riphah International UniversityCompleted
-
Universidad de LeónCompleted
-
RWTH Aachen UniversityCompleted
-
University Health Network, TorontoThe Lung AssociationCompleted
-
Charite University, Berlin, Germanymiha bodytec GmbH; Sonnenfeld-Stiftung; Robert-Enke-StiftungActive, not recruiting
-
University of Erlangen-Nürnberg Medical SchoolUnknownInflammation | Cancer | Muscular Atrophy | Cancer CachexiaGermany
-
Prof. Dr. Frank MoorenCompleted
-
Mackay Memorial HospitalTerminatedCritical Illness Myopathy | Chronic Respiratory FailureTaiwan
-
University of Erlangen-Nürnberg Medical SchoolUnknownMetabolic Syndrome | Overweight and ObesityGermany